Transcat TRNS Q3 2026 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 9 hours ago
0mins
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TRNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TRNS
Wall Street analysts forecast TRNS stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 70.800
Low
95.00
Averages
100.00
High
105.00
Current: 70.800
Low
95.00
Averages
100.00
High
105.00
About TRNS
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Transcat Earnings Preview: Revenue Growth and Market Expectations
- Revenue Performance: Transcat reported $83.86 million in revenue last quarter, a 25.6% year-over-year increase that exceeded analyst expectations, indicating strong market performance despite missing EBITDA estimates.
- Market Expectations: This quarter, the market anticipates a 16.4% year-over-year revenue growth for Transcat, a significant improvement from the 8.8% increase recorded in the same quarter last year, reflecting investor confidence in the company's future performance.
- Analyst Sentiment: Over the past 30 days, most analysts have reaffirmed their estimates for Transcat, suggesting they believe the company will maintain a stable growth trajectory, even though it has missed Wall Street's revenue estimates multiple times over the past two years.
- Peer Performance: In the maintenance and repair distributors segment, VSE Corporation and WESCO reported year-over-year growths of 26.8% and 13.8%, respectively, indicating a positive trend in the industry that may impact Transcat's market performance.
See More
Transcat TRNS Q3 2026 Earnings Call Transcript
See More
Transcat (TRNS) Q2 2026 Earnings Transcript
See More
Transcat to Release Q4 FY2026 Results on May 26, 2026
- Earnings Release Schedule: Transcat will announce its fourth quarter fiscal year 2026 results on May 26, 2026, at 4:30 PM ET, providing crucial insights into its financial and operational performance, which is expected to significantly impact investor sentiment.
- Conference Call Details: CEO Jaime Irick and CFO Thomas Barbato will lead the conference call to review financial results and discuss corporate strategy, followed by a Q&A session, enhancing engagement with investors and stakeholders.
- Replay Availability: A telephonic replay will be accessible starting at 8:30 PM ET on the day of the call until June 9, allowing investors who cannot attend live to access key information through designated dial-in numbers.
- Company Overview: Transcat is a leading provider of testing measurement, control, and calibration services, focusing on highly regulated industries, particularly in life sciences, leveraging its comprehensive service capabilities and distribution platform to drive organic sales growth and market expansion.
See More
Transcat Acquires SCM to Expand Latin American Presence
- Acquisition Overview: Transcat has acquired SCM Metrology and Laboratories, a Costa Rica-based calibration services provider, for approximately $13 million in cash, with the transaction closing on April 9, marking Transcat's first operational presence in Latin America.
- Market Expansion Strategy: This acquisition aims to expand Transcat's footprint in regulated, high-growth markets, as SCM has served multinational medical device and life sciences companies for over 20 years, expected to enhance Transcat's service capabilities and customer reach in the region.
- Service Capability Enhancement: By integrating SCM's expertise and market experience, Transcat will be better positioned to meet the needs of clients in Latin America, thereby increasing its competitiveness in the medical device and life sciences sectors.
- Future Growth Potential: This acquisition not only provides Transcat with an entry point into the Latin American market but also offers strong support for its future organic service growth, anticipated to drive business development in the region.
See More
Transcat Appoints New CEO and Board Member
- Executive Change: Transcat has announced that Jaime Irick will take over as president and CEO effective March 29, 2026, also joining the board and executive committee, indicating a significant leadership shift for the company.
- Current CEO Retirement: Current CEO Lee D. Rudow will retire and step down from the board, yet will remain as a senior advisor until March 2027, ensuring stability during the transition period.
- Strategic Continuity: The appointment of Irick aligns with Transcat's reaffirmation of a high single-digit Q4 organic service growth outlook, indicating the company’s focus on growth while advancing its acquisition strategy.
- Market Reaction: The market response to this executive change has been positive, expected to bolster investor confidence in Transcat's future, particularly as the company reiterates its growth outlook.
See More
Transcat Earnings Preview: Revenue Growth and Market Expectations
- Revenue Performance: Transcat reported $83.86 million in revenue last quarter, a 25.6% year-over-year increase that exceeded analyst expectations, indicating strong market performance despite missing EBITDA estimates.
- Market Expectations: This quarter, the market anticipates a 16.4% year-over-year revenue growth for Transcat, a significant improvement from the 8.8% increase recorded in the same quarter last year, reflecting investor confidence in the company's future performance.
- Analyst Sentiment: Over the past 30 days, most analysts have reaffirmed their estimates for Transcat, suggesting they believe the company will maintain a stable growth trajectory, even though it has missed Wall Street's revenue estimates multiple times over the past two years.
- Peer Performance: In the maintenance and repair distributors segment, VSE Corporation and WESCO reported year-over-year growths of 26.8% and 13.8%, respectively, indicating a positive trend in the industry that may impact Transcat's market performance.
See More
Transcat TRNS Q3 2026 Earnings Call Transcript
See More
Transcat (TRNS) Q2 2026 Earnings Transcript
See More
Transcat to Release Q4 FY2026 Results on May 26, 2026
- Earnings Release Schedule: Transcat will announce its fourth quarter fiscal year 2026 results on May 26, 2026, at 4:30 PM ET, providing crucial insights into its financial and operational performance, which is expected to significantly impact investor sentiment.
- Conference Call Details: CEO Jaime Irick and CFO Thomas Barbato will lead the conference call to review financial results and discuss corporate strategy, followed by a Q&A session, enhancing engagement with investors and stakeholders.
- Replay Availability: A telephonic replay will be accessible starting at 8:30 PM ET on the day of the call until June 9, allowing investors who cannot attend live to access key information through designated dial-in numbers.
- Company Overview: Transcat is a leading provider of testing measurement, control, and calibration services, focusing on highly regulated industries, particularly in life sciences, leveraging its comprehensive service capabilities and distribution platform to drive organic sales growth and market expansion.
See More
Transcat Acquires SCM to Expand Latin American Presence
- Acquisition Overview: Transcat has acquired SCM Metrology and Laboratories, a Costa Rica-based calibration services provider, for approximately $13 million in cash, with the transaction closing on April 9, marking Transcat's first operational presence in Latin America.
- Market Expansion Strategy: This acquisition aims to expand Transcat's footprint in regulated, high-growth markets, as SCM has served multinational medical device and life sciences companies for over 20 years, expected to enhance Transcat's service capabilities and customer reach in the region.
- Service Capability Enhancement: By integrating SCM's expertise and market experience, Transcat will be better positioned to meet the needs of clients in Latin America, thereby increasing its competitiveness in the medical device and life sciences sectors.
- Future Growth Potential: This acquisition not only provides Transcat with an entry point into the Latin American market but also offers strong support for its future organic service growth, anticipated to drive business development in the region.
See More
Transcat Appoints New CEO and Board Member
- Executive Change: Transcat has announced that Jaime Irick will take over as president and CEO effective March 29, 2026, also joining the board and executive committee, indicating a significant leadership shift for the company.
- Current CEO Retirement: Current CEO Lee D. Rudow will retire and step down from the board, yet will remain as a senior advisor until March 2027, ensuring stability during the transition period.
- Strategic Continuity: The appointment of Irick aligns with Transcat's reaffirmation of a high single-digit Q4 organic service growth outlook, indicating the company’s focus on growth while advancing its acquisition strategy.
- Market Reaction: The market response to this executive change has been positive, expected to bolster investor confidence in Transcat's future, particularly as the company reiterates its growth outlook.
See More
